Investment Rating - The report maintains a "Buy" rating for the company with a target price of 60.50 CNY based on a reasonable valuation level of 22 times the earnings for 2025 [2][5][9]. Core Views - The company is experiencing a significant decline in performance due to ongoing policy impacts on the liquor industry, leading to a downward adjustment in revenue and gross margin forecasts. The projected earnings per share for 2025-2027 are 2.75, 3.19, and 3.67 CNY, respectively, down from previous estimates [2][9]. - Despite the current challenges, the company is focusing on optimizing its sales management and internal capabilities, which may provide resilience and recovery potential when the industry cycle turns positive [8][9]. Financial Summary - **Revenue Forecast**: The company's revenue is projected to decline to 6,186 million CNY in 2025, a decrease of 15.8% year-on-year, before recovering to 7,146 million CNY in 2026 and 8,087 million CNY in 2027 [4]. - **Net Profit**: The net profit attributable to the parent company is expected to be 2,203 million CNY in 2025, down 14.9% from the previous year, with a gradual increase to 2,934 million CNY by 2027 [4]. - **Earnings Per Share**: The earnings per share are forecasted to be 2.75 CNY in 2025, with a recovery to 3.19 CNY in 2026 and 3.67 CNY in 2027 [4][9]. - **Profitability Ratios**: The gross margin is expected to stabilize around 73.9% in 2025, with net margin improving to 35.6% [4]. Market Positioning - The company is enhancing its product sales capabilities and refining its pricing management system, focusing on mid-to-high-end products, which are expected to perform better in the current market environment [8]. - The sales organization is being optimized to penetrate both domestic and external markets more effectively, with revenue from domestic markets expected to be 23.6 billion CNY and from external markets 6.3 billion CNY in the first half of 2025 [8]. Valuation Comparison - The report includes a comparison with peer companies, indicating that the average price-to-earnings ratio for comparable companies is around 22 for 2025, supporting the target price of 60.50 CNY for the company [10].